MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Incidence and characteristics of gait dysfunction after subthalamic nucleus deep brain stimulation

V. Velez-Aldahondo, A.B. Millard, J.R. Jagid, C.C. Luca (Miami, FL, USA)

Meeting: 2016 International Congress

Abstract Number: 95

Keywords: Deep brain stimulation (DBS), Gait disorders: Etiology and Pathogenesis

Session Information

Date: Monday, June 20, 2016

Session Title: Surgical therapy: Parkinson's disease

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To identify the effects of subthalamic nucleus deep brain stimulation on gait kinematics in patients with PD and describe the incidence of gait dysfunction after STN DBS.

Background: STN-DBS improves motor scores and mobility in PD patients, however worsening of axial symptoms- predominantly gait – has been described in some cases. The cause of gait worsening is unknown, but it has been proposed that overstimulation or perhaps asymmetric STN stimulation may produce freezing of gait (FOG) inspite of improvement in motor scores.

Methods: 30 patients that underwent STN-DBS were assessed for gait dysfunction 6-12 months after the surgery. Gait kinematics were measured using wireless sensors (APDM Inc). MDS-UPDRS was performed pre and post DBS.

Results: Mean age of PD patients was 62.1 years (+/-10), with an average disease duration of 10.2 years (+/-3.4). Bilateral STN stimulation improved MDS-UPDRS motor score with 55.7% (41.5 +/-10.4 OFF DBS, 18.8 +/-7.5 ON DBS, p < 0.005), and patients were able to reduce the levodopa from 812 mg to 374 mg. Mean velocity after DBS was 1.05 m/s(+/- 0.19) and stride length 1.21 m(+/-0.2). The mean turn time was 3.27s(+/-1) with an average of 6 steps during turn. Patients had high gait variability 0.08(+/-0.04) and increased double limb support 25.5% (+/- 7). In this cohort of 30 patients, 4 complained of worsening gait after DBS inspite of improvement in the motor scores. The velocity was 0.74 m/s with a stride of 0.94 m, turning time of 4.5 seconds and 8 steps per turn. They had greater gait variability (0.11) and higher double limb support 37.4%. Reprogramming of the device with lower frequency improved walking .

Conclusions: STN DBS improves motor scores and gait in PD patients. A minority of patients may experience worsening gait after DBS and reprogramming should be performed with special focus on FOG. Larger studies are necessary to identify the factors associated with increased risks of gait dysfunction after STN-DBS.

To cite this abstract in AMA style:

V. Velez-Aldahondo, A.B. Millard, J.R. Jagid, C.C. Luca. Incidence and characteristics of gait dysfunction after subthalamic nucleus deep brain stimulation [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/incidence-and-characteristics-of-gait-dysfunction-after-subthalamic-nucleus-deep-brain-stimulation/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/incidence-and-characteristics-of-gait-dysfunction-after-subthalamic-nucleus-deep-brain-stimulation/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley